يعرض 81 - 100 نتائج من 33,127 نتيجة بحث عن '(((( 5 ppm decrease ) OR ( a mean decrease ))) OR ( 50 ((mg decrease) OR (a decrease)) ))', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 81
  2. 82
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87

    Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... حسب Ming-Ling Chang (44638)

    منشور في 2022
    "…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …"
  8. 88

    Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... حسب Ming-Ling Chang (44638)

    منشور في 2022
    "…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …"
  9. 89
  10. 90
  11. 91
  12. 92
  13. 93
  14. 94
  15. 95

    Fig 1 - حسب Dalia Zaafar (6693017)

    منشور في 2022
    الموضوعات:
  16. 96

    Fig 3 - حسب Dalia Zaafar (6693017)

    منشور في 2022
    الموضوعات:
  17. 97
  18. 98

    Fig 5 - حسب Dalia Zaafar (6693017)

    منشور في 2022
    الموضوعات:
  19. 99
  20. 100